반응형 gv1001 #alzheimerstreatment #psptherapy #gemvax #clinicaltrialresults #peptidedrug #neurodegenerativediseases #mitochondriaprotection #antiinflammation #globallicensing1 GV1001 Clinical Trial Review: Results and Outlook for Alzheimer’s and PSP Treatments 🔬 1. Summary of GV1001 Alzheimer’s Clinical Trial ResultsGV1001, developed by GemVax, has shown promising results in Phase 2 clinical trials for Alzheimer’s in Korea. Significant cognitive improvement was observed in patients with moderate Alzheimer’s, measured using standard tools such as CDR-SB and MMSE. Compared to the placebo group, the GV1001 group maintained cognitive abilities more effec.. 2025. 4. 6. 이전 1 다음 반응형